Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to demonstrate that dextromethorphan (DXM) and amantadine
compared to placebo exert blood glucose (BG) lowering effects following an oral glucose
tolerance test (OGTT) in male subjects with T2DM.